![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
1 Laboratory of Chemical Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland
A number of recent reports indicate that massive overdoses of acetaminophen can produce a fulminant hepatic necrosis in man. Acetaminophen-induced hepatic necrosis thereforne was examised in experimental animals. Centrilobular hepatic necrosis similar to that seen in man was shown to be dose dependent in mice and rats. To determine whether acetaminophen-induced hepatotoxicity was mediated throug an active metabolite, acetaminophen concentrations in rat and mouse tissues were compared with the severity of liver damage after alteration of the rate of metabolism of acetaminophen. Phenobarbital pretreatment stimulated the disappearance of acetaminophen from tissues but markedly potentiated the hepatic necrosis. In contrast, piperonyl butoxide pretreatment inhibited the metabolism and disappearance of acetaminophen from tissues yet dramatically protected against hepatic necrosis. Additional studies demonstrated that pretreatment with 3-methylcholanthrene also potentiated acetaminophen-induced hepatic necrosis whereas cobaltous chloride, which inhibits synthesis of cytochrome P-450, prevented the hepatic damage. We propose that acetaminophen-induced hepatic necrosis is mediated by a toxic metabolite of acetaminophen.
Submitted on June 29, 1972
This article has been cited by other articles:
|
|
 |
|
  P. J. Murphy The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984-2008 Drug Metab. Dispos., October 1, 2008; 36(10): 1977 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Heard Acetylcysteine for Acetaminophen Poisoning N. Engl. J. Med., July 17, 2008; 359(3): 285 - 292. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Murphy The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 2, 1959-1983 Drug Metab. Dispos., June 1, 2008; 36(6): 981 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Barnes, L. M. Aleksunes, L. Augustine, G. L. Scheffer, M. J. Goedken, A. B. Jakowski, I. M. Pruimboom-Brees, N. J. Cherrington, and J. E. Manautou Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases Drug Metab. Dispos., October 1, 2007; 35(10): 1963 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Williams, D. J. Antoine, P. J. Butler, R. Jones, L. Randle, A. Payne, M. Howard, I. Gardner, J. Blagg, and B. K. Park The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1208 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Gonzalez CYP2E1 Drug Metab. Dispos., January 1, 2007; 35(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Terneus, K. K. Kiningham, A. B. Carpenter, S. B. Sullivan, and M. A. Valentovic Comparison of S-Adenosyl-L-methionine and N-Acetylcysteine Protective Effects on Acetaminophen Hepatic Toxicity J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Chang, C. J. Kochansky, and M. Shou The Role of P-glycoprotein in the Bioactivation of Raloxifene Drug Metab. Dispos., December 1, 2006; 34(12): 2073 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Powell, O. Kosyk, P. K. Ross, R. Schoonhoven, G. Boysen, J. A. Swenberg, A. N. Heinloth, G. A. Boorman, M. L. Cunningham, R. S. Paules, et al. Phenotypic Anchoring of Acetaminophen-Induced Oxidative Stress with Gene Expression Profiles in Rat Liver Toxicol. Sci., September 1, 2006; 93(1): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Soga, R. Baran, M. Suematsu, Y. Ueno, S. Ikeda, T. Sakurakawa, Y. Kakazu, T. Ishikawa, M. Robert, T. Nishioka, et al. Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption J. Biol. Chem., June 16, 2006; 281(24): 16768 - 16776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Yohe, K. A. O'Hara, J. A. Hunt, T. J. Kitzmiller, S. G. Wood, J. L. Bement, W. J. Bement, J. G. Szakacs, S. A. Wrighton, J. M. Jacobs, et al. Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1269 - G1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Sawant, A. V. Dnyanmote, M. S. Mitra, J. Chilakapati, A. Warbritton, J. R. Latendresse, and H. M. Mehendale Protective Effect of Type 2 Diabetes on Acetaminophen-Induced Hepatotoxicity in Male Swiss-Webster Mice J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 507 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jaeschke and M. L. Bajt Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death Toxicol. Sci., January 1, 2006; 89(1): 31 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gu, H. Cui, M. Behr, L. Zhang, Q.-Y. Zhang, W. Yang, J. A. Hinson, and X. Ding In Vivo Mechanisms of Tissue-Selective Drug Toxicity: Effects of Liver-Specific Knockout of the NADPH-Cytochrome P450 Reductase Gene on Acetaminophen Toxicity in Kidney, Lung, and Nasal Mucosa Mol. Pharmacol., March 1, 2005; 67(3): 623 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Wolf and M. J. Wolfe A Brief Overview of Nonneoplastic Hepatic Toxicity in Fish Toxicol Pathol, January 1, 2005; 33(1): 75 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, E. R. Abril, N. W. Bethea, and R. S. McCuskey Inhibition of Matrix Metalloproteinases Minimizes Hepatic Microvascular Injury in Response to Acetaminophen in Mice Toxicol. Sci., January 1, 2005; 83(1): 190 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Irwin, G. A. Boorman, M. L. Cunningham, A. N. Heinloth, D. E. Malarkey, and R. S. Paules Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data Toxicol Pathol, January 1, 2004; 32(1_suppl): 72 - 83. [Abstract] [PDF]
|
|
|
|
|
|
H. Chiu, C. R. Gardner, D. M. Dambach, J. A. Brittingham, S. K. Durham, J. D. Laskin, and D. L. Laskin Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G959 - G966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Slitt, N. J. Cherrington, J. M. Maher, and C. D. Klaassen INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES Drug Metab. Dispos., September 1, 2003; 31(9): 1176 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shankar, V. S. Vaidya, U. M. Apte, J. E. Manautou, M. J. J. Ronis, T. J. Bucci, and H. M. Mehendale Type 1 Diabetic Mice Are Protected from Acetaminophen Hepatotoxicity Toxicol. Sci., June 1, 2003; 73(2): 220 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhao and J. T. Slattery Effects of Ethanol Dose and Ethanol Withdrawal on Rat Liver Mitochondrial Glutathione: Implication of Potentiated Acetaminophen Toxicity in Alcoholics Drug Metab. Dispos., December 1, 2002; 30(12): 1413 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kuffel, J. C. Schroeder, L. J. Pobst, S. Naylor, J. M. Reid, S. H. Kaufmann, and M. M. Ames Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2 Mol. Pharmacol., July 1, 2002; 62(1): 143 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D E Amacher A toxicologist's guide to biomarkers of hepatic response Human and Experimental Toxicology, May 1, 2002; 21(5): 253 - 262. [Abstract] [PDF]
|
|
|
|
|
|
R. Snyder The International Symposium on Biological Reactive Intermediates Toxicol. Sci., April 1, 2002; 66(2): 173 - 175. [Full Text] [PDF]
|
|
|
|
|
|
H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters Mechanisms of Hepatotoxicity Toxicol. Sci., February 1, 2002; 65(2): 166 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Ruepp, R. P. Tonge, J. Shaw, N. Wallis, and F. Pognan Genomics and Proteomics Analysis of Acetaminophen Toxicity in Mouse Liver Toxicol. Sci., January 1, 2002; 65(1): 135 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dong, R. L. Haining, K. E. Thummel, A. E. Rettie, and S. D. Nelson Involvement of Human Cytochrome P450 2D6 in the Bioactivation of Acetaminophen Drug Metab. Dispos., April 13, 2001; 28(12): 1397 - 1400. [Abstract] [Full Text]
|
|
|
|
|
|
A. Enomoto, K. Itoh, E. Nagayoshi, J. Haruta, T. Kimura, T. O'Connor, T. Harada, and M. Yamamoto High Sensitivity of Nrf2 Knockout Mice to Acetaminophen Hepatotoxicity Associated with Decreased Expression of ARE-Regulated Drug Metabolizing Enzymes and Antioxidant Genes Toxicol. Sci., January 1, 2001; 59(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lucas, G. Hennig, P. K. Dominick, H. E. Whiteley, J. C. Roberts, and S. D. Cohen Ribose Cysteine Protects Against Acetaminophen-Induced Hepatic and Renal Toxicity Toxicol Pathol, September 1, 2000; 28(5): 697 - 704. [Abstract] [PDF]
|
|
|
|
|
|
F. A. Nicholls-Grzemski, I. C. Calder, B. G. Priestly, and P. C. Burcham Clofibrate-Induced in Vitro Hepatoprotection against Acetaminophen Is Not Due to Altered Glutathione Homeostasis Toxicol. Sci., July 1, 2000; 56(1): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Lawson, A. Farhood, R. D. Hopper, M. L. Bajt, and H. Jaeschke The Hepatic Inflammatory Response after Acetaminophen Overdose: Role of Neutrophils Toxicol. Sci., April 1, 2000; 54(2): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Kearns, J. S. Leeder, and G. S. Wasserman Acetaminophen Intoxication During Treatment: What You Don't Know Can Hurt You Clinical Pediatrics, March 1, 2000; 39(3): 133 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 P.-G. Forkert, D. D'Costa, and M. El-Mestrah Expression and Inducibility of Alpha, Pi, and Mu Glutathione S-Transferase Protein and mRNA in Murine Lung Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 143 - 152. [Abstract] [Full Text]
|
|
|
|
|
|
L. Trumper, L. A. Monasterolo, and M. M. Elías Probenecid Protects against In Vivo Acetaminophen-Induced Nephrotoxicity in Male Wistar Rats J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 606 - 610. [Abstract] [Full Text]
|
|
|
|
|
|
P. C. Kuo, R. A. Schroeder, and J. Loscalzo Nitric Oxide and Acetaminophen-Mediated Oxidative Injury: Modulation of Interleukin-1-induced Nitric Oxide Synthesis in Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1072 - 1083. [Abstract] [Full Text]
|
|
|
|
|
|
P.-G. Forkert, K. S. Collins, T. F. Dowsley, and G. M. Ross J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1422 - 1430. [Abstract]
|
|
|
|
|
|
N. R. Pumford, N. C. Halmes, B. M. Martin, R. J. Cook, C. Wagner, and J. A. Hinson Covalent Binding of Acetaminophen to N-10-Formyl-Tetrahydrofolate Dehydrogenase in Mice J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 501 - 505. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Ros and H. A. Conrad Baseline Liver Function Tests Following Acetaminophen Ingestion: What is the Utility? Clinical Pediatrics, September 1, 1994; 33(9): 569 - 570. [PDF]
|
|
|
|
 |
|
 H. Calvin, C Medvedovsky, and B. Worgul Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice Science, August 1, 1986; 233(4763): 553 - 555. [Abstract] [PDF]
|
|
|
|
|
|
A Meister Selective modification of glutathione metabolism Science, April 29, 1983; 220(4596): 472 - 477. [Abstract] [PDF]
|
|
|
|
|
|
D. Rollins, C von Bahr, H Glaumann, P Moldeus, and A Rane Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells Science, September 28, 1979; 205(4413): 1414 - 1416. [Abstract] [PDF]
|
|
|
|
 |
|
 P. L. Madan Acetaminophen Toxicity J. Clin. Pharmacol., October 1, 1977; 17(10): 555 - 560. [PDF]
|
|
|
|
|
|
D. M. Jerina and J. W. Daly Arene Oxides: A New Aspect of Drug Metabolism Science, August 16, 1974; 185(4151): 573 - 582. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
